Molecular predictors of immunotherapy efficacy in lung squamous-cell carcinoma (LSCC): Results from the randomized prospective SQUINT trial

Category Primary study
JournalANNALS OF ONCOLOGY
Year 2022
This article has no abstract
Epistemonikos ID: 37629530b13bfdb6ef9a03c162fbb411d9d22abd
First added on: Feb 15, 2025